Ketamine Completed Phase 1 Trials for Schizophrenic Disorders

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT02675530Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism